🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.030
-0.030 (-2.83%)
At close: Nov 18, 2026, 4:00 PM EST
1.015
-0.015 (-1.48%)
Pre-market: Nov 19, 2026, 4:40 AM EST

Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of $78.84 million. The enterprise value is -$37.83 million.

Market Cap78.84M
Enterprise Value -37.83M

Important Dates

The last earnings date was Thursday, November 12, 2026, after market close.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

Cellectis has 100.71 million shares outstanding. The number of shares has increased by 0.31% in one year.

Current Share Class n/a
Shares Outstanding 100.71M
Shares Change (YoY) +0.31%
Shares Change (QoQ) +0.06%
Owned by Insiders (%) 2.12%
Owned by Institutions (%) 16.05%
Float 48.58M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.46
Forward PS 0.54
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.15

Current Ratio 1.15
Quick Ratio 1.12
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -15.24

Financial Efficiency

Return on equity (ROE) is -307.50% and return on invested capital (ROIC) is -78.17%.

Return on Equity (ROE) -307.50%
Return on Assets (ROA) -27.75%
Return on Invested Capital (ROIC) -78.17%
Return on Capital Employed (ROCE) -171.33%
Weighted Average Cost of Capital (WACC) 21.49%
Revenue Per Employee $140,166
Profits Per Employee -$556,227
Employee Count229
Asset Turnover 0.12
Inventory Turnover n/a

Taxes

Income Tax -321,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -75.12% in the last 52 weeks. The beta is 2.94, so Cellectis's price volatility has been higher than the market average.

Beta (5Y) 2.94
52-Week Price Change -75.12%
50-Day Moving Average 1.32
200-Day Moving Average 2.88
Relative Strength Index (RSI) 41.90
Average Volume (20 Days) 67,407

Short Selling Information

The latest short interest is 333,012, so 0.60% of the outstanding shares have been sold short.

Short Interest 333,012
Short Previous Month 320,614
Short % of Shares Out 0.60%
Short % of Float n/a
Short Ratio (days to cover) 3.16

Income Statement

In the last 12 months, Cellectis had revenue of $32.10 million and -$127.38 million in losses. Loss per share was -$1.22.

Revenue32.10M
Gross Profit 32.10M
Operating Income -123.55M
Pretax Income -127.70M
Net Income -127.38M
EBITDA -112.13M
EBIT -123.55M
Loss Per Share -$1.22
Full Income Statement

Balance Sheet

The company has $146.71 million in cash and $25.88 million in debt, with a net cash position of $120.82 million or $1.20 per share.

Cash & Cash Equivalents 146.71M
Total Debt 25.88M
Net Cash 120.82M
Net Cash Per Share $1.20
Equity (Book Value) -17.63M
Book Value Per Share -0.18
Working Capital 21.89M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.63 million and capital expenditures -$2.18 million, giving a free cash flow of -$43.80 million.

Operating Cash Flow -41.63M
Capital Expenditures -2.18M
Depreciation & Amortization 11.43M
Net Borrowing -16.36M
Free Cash Flow -43.80M
FCF Per Share -$0.43
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -384.93%
Pretax Margin -397.83%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -0.31%
Shareholder Yield -0.31%
Earnings Yield -118.74%
FCF Yield -55.56%

Analyst Forecast

The average price target for Cellectis is $4.45, which is 332.04% higher than the current price. The consensus rating is "Buy".

Price Target $4.45
Price Target Difference 332.04%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (3Y) -20.99%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1